Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by edmedon Mar 18, 2015 10:25pm
97 Views
Post# 23536806

RE:RE:gotta love it..

RE:RE:gotta love it..


Actually you have no Idea what you are talking about.
Safety and efficacy studies are only done by the Original brand name pharmaceutical companies.
These studies cost millions of dollars and take years to do.
Generic companies copy the molecule with some side chain variations to the molecule that generally do not involve the active part of the molecule
To get accepted they merely have to do a study on healthy young male patients showing an acceptable level of absorption and bioavailablility.
that is it.

Generics are a cost effective way of treating the masses in a system where costs are spiraling out of control
As such, they are a necessary reality.

To be successful Vanc will have to watch their quality control from their manufacturers.  There is little room for error here. 
good luck to all
JMHO

Bullboard Posts